metformin vs glp 1 for pcos Semaglutide and improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial The dual impact of GLP-1
Description
Taati M, Barzegar PEF, Raisi A
Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism
If side effects become severe, speak to your prescriber about adjusting your treatment
38% say they used the medications only to lose weight
While these medications offer glycemic control and cardiovascular benefits, the risks have increased because of their potential impact on cancer risk, particularly colorectal cancer (CRC)
Bracchiglione J, Meza N, Franco JV, et al
